title: Assessing the impact of HL7/FDA Structured Product Label (SPL) content for medication knowledge management.
abstract: The amount and quality of the SPL drug knowledge which has been released so far is assessed. All published labels were loaded into a relational database and classified to create vendor-independent descriptions. While SPL labels cover only 23% of RxNorm clinical drugs, they still describe 78% of actual community pharmacy dispenses records. SPL descriptions agree well with RxNorm. SPL can be used as the primary source of drug information for e-prescribing systems once the upcoming FDA listing rule takes effect. In the interim, existing gaps can be temporarily closed with RxNorm or other sources.
authors.affiliation: Regenstrief Institute, Indiana University School of Informatics, Indianapolis, IN, USA.
authors.forename: Gunther
authors.initials: G
authors.lastname: Schadow
mesh_terms: D004348:Drug Labeling / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D019451:Information Management; D020407:Internet; D050316:Medical Order Entry Systems; D004364:Pharmaceutical Preparations / Q000145:classification*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations